Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Dec82016
Events

MGA’s Alex Brill Serves as a Panelist at the National Coalition on Health Care’s Capitol Hill Forum

From the Coalition to Protect Patient Choice:

“The last panelist was Alex Brill… [who] spoke about FDA reform and specifically about patent issues relating to biologic drugs and their generic counterparts known as biosimilars. He stated that biosimilar entry has not been as robust as was envisioned by the Affordable Care Act, due to archaic regulatory schemes, anticompetitive conduct, and cost-benefit analysis.”

Read Here

December 8, 2016Category: Events

Post navigation

PreviousPrevious post:Trump Tax Plan Could Negatively Impact GivingNextNext post:MGA’s Alex Brill Serves as a Panelist at AEI’s “Setting Priorities for Governing”
  • Analysis(28)
  • Books(2)
  • Events(13)
  • Interviews(33)
  • News(44)
  • Op-Eds(59)
  • Press Releases(2)
  • Testimony(18)
  • MGA Analysis of Potential Savings from Complex Generics Cited in Multiple Publications
    February 12, 2021
  • New MGA Report on the Potential Savings from Accelerating US Approval of Complex Generics
    February 9, 2021
  • Almost-Speaker McCarthy
    November 23, 2020
  • Nursing Homes Prepare for Third COVID-19 Surge
    October 26, 2020

Website Design and Developed by DreamBig Creative